{"id":5344,"date":"2025-11-06T12:38:08","date_gmt":"2025-11-06T12:38:08","guid":{"rendered":"https:\/\/intereconomia.com\/?p=1028281"},"modified":"2025-11-06T12:38:08","modified_gmt":"2025-11-06T12:38:08","slug":"pharmamar-recibe-mas-de-85-millones-de-janssen-por-la-venta-de-yondelis-en-eeuu","status":"publish","type":"post","link":"https:\/\/hlrnet.net\/sites\/negocios\/2025\/11\/06\/pharmamar-recibe-mas-de-85-millones-de-janssen-por-la-venta-de-yondelis-en-eeuu\/","title":{"rendered":"PharmaMar recibe m\u00e1s de 8,5 millones de Janssen por la venta de Yondelis en EEUU"},"content":{"rendered":"\n\n<div class=\"kk-star-ratings kksr-auto kksr-align-left kksr-valign-top\"\n    data-payload='{&quot;align&quot;:&quot;left&quot;,&quot;id&quot;:&quot;5344&quot;,&quot;slug&quot;:&quot;default&quot;,&quot;valign&quot;:&quot;top&quot;,&quot;ignore&quot;:&quot;&quot;,&quot;reference&quot;:&quot;auto&quot;,&quot;class&quot;:&quot;&quot;,&quot;count&quot;:&quot;0&quot;,&quot;legendonly&quot;:&quot;&quot;,&quot;readonly&quot;:&quot;&quot;,&quot;score&quot;:&quot;0&quot;,&quot;starsonly&quot;:&quot;&quot;,&quot;best&quot;:&quot;5&quot;,&quot;gap&quot;:&quot;5&quot;,&quot;greet&quot;:&quot;Rate this post&quot;,&quot;legend&quot;:&quot;0\\\/5 - (0 votos)&quot;,&quot;size&quot;:&quot;24&quot;,&quot;title&quot;:&quot;PharmaMar recibe m\u00e1s de 8,5 millones de Janssen por la venta de Yondelis en EEUU&quot;,&quot;width&quot;:&quot;0&quot;,&quot;_legend&quot;:&quot;{score}\\\/{best} - ({count} {votes})&quot;,&quot;font_factor&quot;:&quot;1.25&quot;}'>\n            \n<div class=\"kksr-stars\">\n    \n<div class=\"kksr-stars-inactive\">\n            <div class=\"kksr-star\" data-star=\"1\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n            <div class=\"kksr-star\" data-star=\"2\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n            <div class=\"kksr-star\" data-star=\"3\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n            <div class=\"kksr-star\" data-star=\"4\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n            <div class=\"kksr-star\" data-star=\"5\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n    <\/div>\n    \n<div class=\"kksr-stars-active\" style=\"width: 0px;\">\n            <div class=\"kksr-star\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n            <div class=\"kksr-star\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n            <div class=\"kksr-star\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n            <div class=\"kksr-star\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n            <div class=\"kksr-star\" style=\"padding-right: 5px\">\n            \n\n<div class=\"kksr-icon\" style=\"width: 24px; height: 24px;\"><\/div>\n        <\/div>\n    <\/div>\n<\/div>\n                \n\n<div class=\"kksr-legend\" style=\"font-size: 19.2px;\">\n            <span class=\"kksr-muted\">Rate this post<\/span>\n    <\/div>\n    <\/div>\n\n<p>La <a href=\"https:\/\/pharmamar.com\/es\/\" target=\"_blank\" rel=\"noreferrer noopener\">empresa PharmaMar<\/a> ha recibido 10 millones de d\u00f3lares (unos 8,7 millones de euros) de la farmac\u00e9utica belga Janssen por el hito comercial logrado con el acuerdo de licencia para la comercializaci\u00f3n y distribuci\u00f3n de Yondelis (trabectedina) en Estados Unidos.<\/p>\n<p>Seg\u00fan ha informado este jueves PharmaMar a la <a href=\"https:\/\/intereconomia.com\/tag\/cnmv\/\" target=\"_blank\" rel=\"noreferrer noopener\">Comisi\u00f3n Nacional del Mercado de Valores (CNMV)<\/a>, en agosto de 2019 la compa\u00f1\u00eda firm\u00f3 un nuevo acuerdo de licencia con la filial de Johnson &amp; Johnson que reemplaz\u00f3 el de 2001, bajo el cual Janssen se reservaba el derecho de vender y distribuir con car\u00e1cter exclusivo este medicamento en Estados Unidos.<\/p>\n<p>Este medicamento es el segundo m\u00e1s importante en los ingresos de PharmaMar, por detr\u00e1s de Zepzelca, y en los nueve primeros meses del a\u00f1o le report\u00f3 al laboratorio m\u00e1s de 20 millones de euros en ingresos entre ventas y royalties.<\/p>\n<p>La trabectedina est\u00e1 aprobada en m\u00e1s de 70 pa\u00edses para el tratamiento de sarcoma de tejidos blandos y tambi\u00e9n en algunos de estos pa\u00edses para el c\u00e1ncer de ovario.<\/p>\n<\/p>\n<p>The post <a href=\"https:\/\/intereconomia.com\/noticia\/empresas\/pharmamar-recibe-mas-de-85-millones-de-janssen-por-la-venta-de-yondelis-en-eeuu-20251106-1338\/\">PharmaMar recibe m\u00e1s de 8,5 millones de Janssen por la venta de Yondelis en EEUU<\/a> appeared first on <a href=\"https:\/\/intereconomia.com\">Radio Intereconom\u00eda<\/a>.<\/p>\n<p\/>Fuente: <a href=\"https:\/\/intereconomia.com\/noticia\/empresas\/pharmamar-recibe-mas-de-85-millones-de-janssen-por-la-venta-de-yondelis-en-eeuu-20251106-1338\/\" class=\"autohyperlink\">intereconomia.com\/noticia\/empresas\/pharmamar-recibe-mas-de-85-millones-de-janssen-por-la-venta-de-yondelis-en-eeuu-20251106-1338\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La empresa PharmaMar ha recibido 10 millones de d\u00f3lares (unos 8,7 millones de euros) de la farmac\u00e9utica belga Janssen por el hito comercial logrado con el acuerdo de licencia para la comercializaci\u00f3n y distribuci\u00f3n de Yondelis (trabectedina) en Estados Unidos. Seg\u00fan ha informado este jueves PharmaMar a la Comisi\u00f3n Nacional<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-5344","post","type-post","status-publish","format-standard","hentry","category-prensa-especializada"],"publishpress_future_action":{"enabled":false,"date":"2026-05-01 08:14:54","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/hlrnet.net\/sites\/negocios\/wp-json\/wp\/v2\/posts\/5344","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hlrnet.net\/sites\/negocios\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hlrnet.net\/sites\/negocios\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hlrnet.net\/sites\/negocios\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/hlrnet.net\/sites\/negocios\/wp-json\/wp\/v2\/comments?post=5344"}],"version-history":[{"count":0,"href":"https:\/\/hlrnet.net\/sites\/negocios\/wp-json\/wp\/v2\/posts\/5344\/revisions"}],"wp:attachment":[{"href":"https:\/\/hlrnet.net\/sites\/negocios\/wp-json\/wp\/v2\/media?parent=5344"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hlrnet.net\/sites\/negocios\/wp-json\/wp\/v2\/categories?post=5344"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hlrnet.net\/sites\/negocios\/wp-json\/wp\/v2\/tags?post=5344"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}